CompletedNot Applicable

Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

Egypt60 participantsStarted 2023-09-01

Plain-language summary

The study aimed to evaluate the role of Protein S100B versus the neutrophil-to-lymphocyte ratio (NLR) as an early predictor biomarker and the value of amplitude-integrated electroencephalography (aEEG) as an early predictor and prognostic method for neonatal brain injury susceptibility and severity.

Who can participate

Age range28 Weeks – 36 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gestational age between 28 and 36 weeks. * Prematurity. Exclusion Criteria: * Intrauterine growth restriction (IUGR). * Multiple congenital anomalies. * Chromosomal abnormalities. * Preterm less than 28 weeks. * Infant of diabetic mother.

What they're measuring

Protein S100B

Timeframe: Third day of seizure activity

Trial details

NCT IDNCT07093723

SponsorTanta University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More S100B trials